Home > Insider Trading > Filing (0001127602-22-000457)

Filing Details

Accession Number:: 0001127602-22-000457
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-04 16:19:53
Reporting Period:: 2021-12-31

Accepted Time:: 2022-01-04 16:19:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145197	Insulet Corp	PODD	Surgical & Medical Instruments & Apparatus (3841)	043523891

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1768648	D. Wayde Mcmillan	C/O Insulet Corporation 100 Nagog Park Acton MA 01720	Evp, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-12-31	193	$266.37	21,740	No	4	S	Direct
Common Stock	Disposition	2021-12-31	400	$267.82	21,340	No	4	S	Direct
Common Stock	Disposition	2021-12-31	500	$268.88	20,840	No	4	S	Direct
Common Stock	Disposition	2021-12-31	672	$270.19	20,168	No	4	S	Direct
Common Stock	Disposition	2021-12-31	90	$271.23	20,078	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.04 to $266.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $267.45 to $268.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $268.47 to $269.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.86 to $270.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.